peripheral lymphocytes in vitro (Shafer et al., 1987) . It also suppresses unscheduled DNA synthesis (UDS) in hypoFluphenazine, an antipsychotic drug that belongs to the thalamic cells of rats chronically treated with the drug (Š ram phenothiazine family, reduced the genotoxicity of standard et al., 1990) . Since fluphenazine is used in humans in the direct-and indirect-acting mutagens in the Ames test, both treatment of various psychoses, these doubts should be disin the presence and in the absence of promutagen-activating pelled and the drug's action on mutagenesis and carcinogen-S9 fraction. In short-term tests on human lymphocytes, esis clarified. the inhibitory effect of fluphenazine on the genotoxicity of Fluphenazine is a piperazine phenothiazine that is structurstandard mutagens was strongest in the cytokinesis-blocked ally similar to perphenazine and prochlorperazine (Budavari, micronucleus assay and in the thioguanine-resistance test , 1996) . Its general chemical formula is given in Figure 1 . The and weakest in the sister chromatid exchange test. Fluphenchemical structure of fluphenazine suggests that it could form azine also considerably reduced the level of free radicals complexes with and/or reduce chemical mutagens and also estimated in in vitro samples of human granulocytes. The scavenge free radicals. results suggest that, in the range of the tested concentra-
The aim of this study was to evaluate in vitro the effect of tions, fluphenazine could be considered for use to prevent fluphenazine on the genotoxicity of standard mutagens in a the genotoxicity of daunorubicin, methyl methanesulfonate,
battery of short-term tests, including the bacterial Ames test benzo[a]pyrene and mitomycin C. Reduction in the level
and three short-term assays on human lymphocytes. The effect of free radicals appears to be an important mechanism of of fluphenazine on the generation of free radicals in human the antimutagenic action of fluphenazine.
granulocytes was also estimated, because of the importance of free radicals in mutagenesis and carcinogenesis (e.g. see Troll and Weisner, 1985; Marnett, 1987; Cavalieri and Rogan, Introduction 1992; Frenkel, 1992) and because the chemical structure of fluphenazine suggested it might have radical-scavenging Analysis of clinical data, in which unexpected beneficial sideactivity. effects of commonly used drugs were discerned, has led
The lymphocyte short-term assays were carried out with to the identification of several antimutagenic and cancercells separated from the venous blood of psychiatric clinic chemopreventive compounds among old drugs. Similarly, it patients to whom fluphenazine had been prescribed as the has been shown that phenothiazines significantly reduce the main drug for treatment of their mental disorder. Since these incidence of cancer among schizophrenic patients treated patients were also heavy smokers, and thus would have been with them (Katz et al., 1967; Jones, 1985) . This suggested exposed to higher concentrations of genotoxic agents, we that phenothiazines could have antimutagenic and cancerintended to check whether fluphenazine would be effective in chemopreventive activity in humans. The phenothiazine family decreasing the genotoxicity of standard mutagens in their includes major tranquillizers used to treat psychotic disorders, blood cells in vitro. such as schizophrenia, mania, paranoid syndromes and alcoholic hallucinosis. The finding that phenothiazines reduce the incidence of cancer in humans generated a broad range of Materials and methods experimental studies, which confirmed their antitumor, cancerChemicals chemopreventive and antimutagenic activities (e.g. Jones, Fluphenazine-HCl, analytical grade, was kindly supplied by Jelfa (Jelenia 1985; Leszek et al., 1988; Motohashi et al., 1991; Tanaka Góra, Poland) . B[a]P, daunorubicin (DRC), methyl methanesulfonate (MMS), et al., 1997).
cytochalasin B, mitomycin C (MMC), 5-bromo-2Ј-deoxyuridine (BrdUrd), phorbol 12-myristate 13-acetate (PMA) and dimethyl sulfoxide (DMSO) were Fluphenazine is a member of the phenothiazine drug family purchased from Sigma (St Louis, MO). Aroclor 1254 was from Analabs (New and is often used in the treatment of various psychoses, mainly Haven, CT). In the preparation of bacterial growth media, Oxoid Nutrient schizophrenia and paranoid syndromes. However, the fact that Broth no. 2 (Oxoid, Basingstoke, UK), Difco Bacto Nutrient Broth and Difco it is a member of this family does not mean that it will Agar (Difco, Detroit, MI), glucose 6-phosphate and NADP (Sigma) were used.
also have antimutagenic and cancer-chemopreventive action.
Blood-cell separation solutions (Histopaque-1077 and Histopaque-1119) and components of cell culture media [RPMI 1640, fetal calf serum (FCS) Published studies on fluphenazine's genotoxicity in short-term and L-glutamine] were obtained from Sigma. Phytohemagglutinin (PHA-M) tests and on its effects on the genotoxicity of standard mutagens was obtained from Gibco (Gaithersburg, MD). Acridine Orange, ethidium have not provided an unequivocal answer. In the standard bromide, Azur II, eosin B, Trypan Blue, Giemsa solution and nitroblue bacterial Ames test, fluphenazine, like other tested phenotetrazolium (NBT) were purchased from Sigma. Other reagents used for preparing buffers and culture media were from POCH (Gliwice, Poland).
thiazines, reduces the mutagenicity of benzo [a] pyrene (Calle Therefore, we carried out the tests with human lymphocytes at fluphenazine concentrations of ഛ5 µM in the culture medium. Sister chromatid exchange assay Lymphocytes were cultured in 24-well plastic dishes at 5 ϫ 10 5 cells/ml in complete culture medium (RPMI 1640, 10% FCS, 2 mM L-glutamine) and stimulated to mitogenesis with PHA-M (1% v/v) for 72 h. The tested mutagen, B[a]P, was dissolved with DMSO and added to the culture in a 50 µl volume to obtain the desired final concentration. We did not apply an external promutagen activating fraction, because freshly prepared human lymphocytes have a microsomal enzymatic system which activates polyaromatic hydrocarbons to form genotoxic derivatives (Guengerich, 1992; Goldstein and Faletto, 1993) . Fluphenazine, dissolved in distilled water, was added simultaneously to the culture in a volume of 50 µl to obtain the final concentrations in a culture medium. The thymidine analogue, BrdUrd, was added for the last 48 h of the culture time at a final concentration of 30 µM. The cultures were Fig. 1 . Chemical formula of fluphenazine.
harvested according to the standard cytogenetic method. Cell smears on glass slides were air-dried for 3 days. Afterwards, the slides were immersed in 2ϫ SSC (0.03 M sodium citrate in 0.3 M sodium chloride) at 62°C for 30 min The Ames test and, simultaneously, they were illuminated under a UV lamp (Perry and The effect of fluphenazine on the mutagenic activity of standard mutagens Wolff, 1974) . The slides were then stained with a mixture of dyes (azur II/ was estimated using the Salmonella typhimurium tester strains recommended eosin) to reveal the differential chromatid staining (Antoshina and Poriadkova, for particular mutagens (Ames et al., 1975; Maron and Ames, 1983 Ames, 1983) in the presence or absence of promutagen-activating fraction S9. The fraction was prepared according to Ames et al. (1975) from the liver
The replication indices (RIs) of lymphocyte cultures were estimated by of Aroclor 1254-treated male Wistar rats. The fluphenazine was dissolved in counting the number of metaphases that were in the first (M 1 ), second (M 2 ) distilled water and added at 5, 10, 25 or 50 µmol/plate, in consecutive or third (M 3 ) division in the presence of BrdUrd and calculated according to plates. B[a]P and MMS were dissolved in DMSO, while DRC was dissolved the formula RI ϭ (M 1 ϩ 2M 2 ϩ 3M 3 )/100. The mitotic indices (MIs) were in distilled water; these standard mutagens were added to tester plates at the determined in each culture's slide within 1000 cells found randomly by concentrations recommended by Maron and Ames (1983) : B[a]P, 2.5 µg/ microscope examination. The proliferation potential was calculated as the plate; MMS, 0.5 µg/plate; DRC, 0.5 µg/plate. The tested mixtures contained product of MI and RI for each lymphocyte culture. 0.1 ml of mutagen solution, 0.1 ml of fluphenazine solution, 0.1 ml of Cytokinesis-blocked micronucleus assay overnight cultures of the S.typhimurium tester strain and 0.5 ml of the S9 mix
The lymphocyte micronucleus assay was performed by cytokinesis-blocked (10% S9, v/v) or 0.5 ml of phosphate buffer (pH 7.4), and 2 ml of top agar. assay in accordance with standard procedures (Fenech, 1993 ; Lee et al., The mixtures were poured on to minimal glucose agar plates. To determine 1994). Briefly, lymphocyte cultures were stimulated with the lectin PHA-M the number of surviving bacterial cells, 0.1 ml of each tested mixture was (1% v/v) and the standard micronucleus-inducing clastogenic agent, MMC, diluted 10 7 -fold and then poured on to nutrient agar plates. The numbers of was added to the culture medium to give a final concentration of 0.03 µg/ml. revertants and viable cells were counted after incubation for 2 days at 37°C.
Fluphenazine dissolved in water was added to the cultures in a volume of The number of surviving bacterial cells was calculated as the number of 50 µl to give the required final concentration. Control cultures contained the viable cells/plate multplied by 10 7 (Maron and Ames, 1983) . The results same volume of water instead of MMC and/or fluphenazine. MMC and obtained in the Ames test (mean Ϯ SD; n ϭ 6) are presented in histograms fluphenazine were present in the culture medium for the whole period of as the net number of his ϩ revertants, i.e. the number after subtraction of culture, i.e. for 72 h. Lymphocytes were exposed to a cytokinesis-blocking spontaneous revertant numbers. agent, cytochalasin B, added to give a final concentration of 4.5 µg/ml of Separation of blood cells culture medium, for the last 48 h of this culture period. The cultures were Heparinized blood (20 ml) was obtained by venipuncture from five males harvested according to Lee et al. (1994) with mild hypotonic treatment aged 43-50 years, each of whom smoked 20-30 cigarettes/day. The blood (0.075 M KCl for 10 min) followed by fixation with cold methanol:acetic donors were all from the psychiatric clinic (none had been admitted previously); acid (3:1). The cell suspension was gently spread on microscope slides, dried two of them were diagnosed as suffering from schizophrenic psychosis, and and stained with 10% Giemsa solution (in PBS, pH 6.8) for 5 min. Slides three others from non-specific paranoid syndromes. Except for suffering from were examined under a microscope and the number of micronuclei in 1000 a psychiatric disorder, the patients were generally healthy. The blood cells binucleated lymphocytes was counted. were separated by a single-step discontinuous density-gradient centrifugation Thioguanine-resistance assay technique with Histopaque-1119 and Histopaque-1077 layers (English and Lymphocytes were suspended in culture medium and stored in a plastic culture Anderson, 1974) . Isolated lymphocytes and granulocytes were washed in bottle for 18 h at 4°C to prevent phenocopies. They were then suspended in phosphate-buffered saline (PBS), pH 7.2. fresh medium and cultured for 48 h according to published protocols (OstroskyEstimation of fluphenazine doses with lymphocyte survival test Wegman et al., 1987; Montero et al., 1993) , with minor modifications. Briefly, 0.8 ϫ 10 6 cells/ml were cultured in 24-well plastic dishes and stimulated with The effect of fluphenazine on the viability of human lymphocytes in 4 and 18 h cultures was assessed with the standard Trypan Blue exclusion test and PHA-M (1% v/v) in the presence of 2 ϫ 10 -4 M thioguanine. The tested mutagen, B[a]P (16 µM), and supposed antimutagen, fluphenazine (concentrawith double fluorescence staining of nucleic acids with acridine orange/ ethidium bromide. Briefly, cell samples were suspended with 0.4% Trypan tion range: 0.625-5 µM), were added at the start of culture. After 24 h, BrdUrd (30 µM) was added to the cultures for 24 h. The harvesting procedure Blue in PBS, pH 7.4, and incubated for 10 min. Smears were made on glass slides and the number of blue-stained (dead) cells among 2000 cells was comprised centrifugation of the cultures, fixation of pellets with 75% ethanol for 30 min, treatment with lysis solution (0.2 mg/ml RNase; 0.5 mM disodium counted by microscopy (e.g. see Fernandez-Botran and Větvička, 1995) . In the fluorescent staining method, cell samples suspended in PBS were stained EDTA and 0.5% Nonidet P-40) for 30 min at 10°C. For partial denaturation of DNA, the cell pellets were resuspended in 0.5 N HCl, kept at room with the dye mixture, dissolved in PBS. The final concentration of each stain in the cell sample was 40 nM. After the dyes had been added, smears on temperature for 30 min and washed twice with PBS; smears were prepared on microscope slides. Cells in which BrdUrd had been incorporated into the glass slides were immediately examined under a fluorescent microscope and the number of viable (green) cells and dead (yellow to orange) cells among DNA were detected by an immunocytochemical procedure using a monoclonal mouse antibody able to recognize BrdUrd in single-stranded DNA (clone 200 cells was counted for each sample (e.g. see Duke and Cohen, 1992; Da'browska et al., 1996) . Bu20a, DAKO, Glostrup, Denmark). Subsequent visualization and staining were performed using the alkaline phosphatase anti-alkaline phosphatase Both staining methods proved that fluphenazine was not cytotoxic to human lymphocytes in vitro in the range of the tested concentrations (0.625-5 µM (APAAP) technique (Cordell et al., 1984; Vanderlaan and Thomas, 1985; Magaud et al., 1988) . Thioguanine-resistant lymphocytes (which become in culture medium). Fluphenazine was also not cytotoxic to cells when present in the culture together with B[a]P (16 µM) or MMC (0.03 µg/ml). At higher intensely stained red) were counted among 5000 cells randomly found under the microscope. concentrations of the drug, a considerable cytotoxic effect was noticed.
Antimutagenicity of fluphenazine
Estimation of granulocyte superoxide radicals CBMN assay (Ͼ70% decrease at the highest fluphenazine
The influence of fluphenazine on superoxide radical generation by human concentration), moderate in the thioguanine resistance test granulocytes in vitro was evaluated using the routine NBT reduction test (25% decrease) and weakest (~20% decrease) in the sister (Metcalf et al., 1986) were then lysed with dimethylformamide at 56°C in a shaking bath and
The slopes of the regression lines shown in Figure 3 were of absorption (A 515nm ) relative to that of cell-free blank samples was measured using a spectrophotometer. negative direction and were significantly different from zero.
Statistical analysis
MANOVA showed that the effect of fluphenazine on lymphocyte cultures was significantly concentration-dependent (F ϭ
The results obtained with the Ames test were examined by means of the standard t-test to determine their statistical significance. Regression equations 243.29; three degress of freedom; P Ͻ 10 -6 ). It also estimated were calculated to see whether the observed effects of fluphenazine on significant differences between the applied tests in their descriplymphocytes and granulocytes were significantly dose-related. For this purpose, tion of the fluphenazine effect (F ϭ 810.56; three degrees of we estimated if the slopes of the regression curves (a 1 ) were significantly freedom; P Ͻ 10 -6 ). different from zero. Multifactor analysis of variance (MANOVA) was performed in order to assess the significance of differences between various test
The level of free radicals in control granulocyte samples systems and to confirm the significance of dose-response relations. All was estimated spectrophotometrically; the A 515nm (mean statistical estimations were computed using Systat software (Evanston, IL, Ϯ SD; n ϭ 5) was as follows: sample containing PMA USA).
(100 ng/ml), 0.117 Ϯ 0.011; sample containing 16 µM B[a]P, 0.078 Ϯ 0.0094; sample containing solvent only (DMSO, Results 10 µl), 0.055 Ϯ 0.0089. We took these results as reference levels (E 0 ), with which the results of fluphenazine impact were We evaluated the effect of fluphenazine on the genotoxicity of standard mutagens in the Ames test. When used alone or compared, and presented as an E/E 0 ratio. The effect of fluphenazine on the level of free radicals in together with a mutagen, fluphenazine at concentrations of ഛ50 µmol/plate did not inhibit the growth of bacterial cells, human granulocytes is shown in Figure 4 . In samples where solely fluphenazine was present (spontaneous release, without whereas at higher concentrations it had a considerable inhibitory effect. Therefore, the highest dose of fluphenazine PMA) the level of free radicals was 55% lower than in control samples. In the granulocyte samples in which the standard evaluated by us in the Ames test was 50 µmol/plate.
The effects of fluphenazine on the standard indirectly acting free radical-cascade activator (PMA, 100 ng/ml) was present, fluphenazine reduced the level of free radicals by 25% mutagen, B[a]P, and two directly acting mutagens, MMS and DRC, are shown in Figure 2 . Fluphenazine moderately (at 10 µM) compared with the samples in which solely PMA was present. In the presence of the promutagen B[a]P decreased the genotoxic effect of B[a]P in the Ames test. At the highest fluphenazine concentration tested (50 µmol/plate), (16 µM), fluphenazine reduced the level of free radicals in granulocytes by ഛ40% at the highest concentration tested. there was a 20% decrease in B[a]P mutagenic activity ( Figure  2A ). In the case of directly acting mutagens, tested without Regression equations showed that the inhibition by fluphenazine was strongly concentration-dependent; the slopes of the the presence of S9 fraction ( Figure 2C and D), fluphenazine had a weak effect on the genotoxicity of MMS (causing a regression lines were significantly different from zero. Analysis of variance confirmed this concentration-dependence (F ϭ 14% decrease at the highest concentration tested); in the case of DRC, the inhibitory effect of fluphenazine was stronger (by 200.02; four degrees of freedom; P Ͻ10 -6 ). almost 50% at the highest concentration tested). We also tested the genotoxicity of DRC in the presence of the S9 fraction Discussion and the effect of fluphenazine on the mutagenic activity of DRC in the TA 98 ϩ S9 system. The results are shown in
The question of the genotoxicity and/or anti-genotoxicity of fluphenazine still remains controversial, some reports suggest- Figure 2B . As may be seen, fluphenazine decreased the mutagenic action of DRC in the presence of S9 fraction by ing that it is mutagenic while others suggest that it is antimutagenic. Extensive work with the Ames test showed that25% at the highest concentration tested, and the inhibitory effect was concentration-dependent.
phenothiazines were not mutagenic in vitro either in the presence or in the absence of microsomal S9 fraction (Balbi In human lymphocyte cultures we estimated the background genetic damage caused by 16 µM B[a]P and 0.03 µg/ml MMC et al., 1980) . On the other hand, in short-term human lymphocyte tests, fluphenazine at concentrations of 2.5-10 µg/ml (i.e. by assaying four different end-points. The results obtained using lymphocytes from five blood donors were collected and 4.89 -19.59 µM) significantly increased chromosome damage and the frequency of sister chromatid exchange (Shafer et al., are given in Table I as a mean Ϯ SD. The results presented in Table I were taken as reference values (E 0 ) with which we 1987); however, these authors acknowledged that the tested doses were high and noted the need for low-dose studies. compared data on the effect of fluphenazine on the genotoxicity of standard mutagens (E/E 0 ratio).
In our initial experiments (data not shown), the genotoxicity of fluphenazine was evaluated by means of a sister chromatid The effect of fluphenazine on the mutagenicity of 16 µM B[a]P or 0.03 µg/ml MMC to human lymphocytes in vitro is exchange test in human lymphocyte cultures at concentrations ranging from 0.625 to 5.0 µM (i.e. 0.319-2.55 µg/ml). The shown in Figure 3 in the form of linear regression lines describing the dependence of effects on the concentration of calculated regression equation showed that changes in the frequency of sister chromatid exchange did not depend on fluphenazine in a culture medium. As may be seen from this figure, the inhibitory effect of fluphenazine was greatest in the the fluphenazine concentration in the culture medium (F ϭ 2.526; P ϭ 0.1872; not significant). The discrepancy between The antimutagenic action of fluphenazine is another issue. It has been documented in the literature that phenothiazine our results and previously cited results may have been caused by the difference in the ranges of fluphenazine concentrations and its derivatives inhibit the mutagenicity of B[a]P in the Ames test (Kittle et al., 1981; Calle and Sullivan, 1982) . Our tested. We chose low concentrations (ഛ5 µM), since at 10 µM (i.e. 5.1 µg/ml) a considerable increase in the number of dead results obtained with the Ames test showed that fluphenazine had a rather mild antimutagenic effect on the genotoxicity of lymphocytes occurred. carbons by one-electron oxidation, yielding genotoxic free radicals (Cavalieri and Rogan, 1992; Frenkel, 1992) . Those oxidation pathways could be inhibited by fluphenazine, since it is able to decrease free radical levels.
At present it is difficult to explain the observed antimutagenic effects of fluphenazine against the directly acting mutagens DRC, MMC and MMS. Indeed, several papers have proved that directly acting mutagens, such as MMC and DRC, are modified inside the cell by intracellular oxido-reductases (Farmer, 1985; Parke, 1987) . We noticed that the mutagenic activity of DRC was almost 30% higher in the presence of the S9 fraction. However, the effect of fluphenazine on the mutagenicity of DRC was weaker in the presence of the S9 fraction than in the absence of the S9 (decrease by 25% and 50%, respectively). This suggests that inhibition of the S9 free radical pathways by the drug may not be the only mechanism of fluphenazine's antimutagenic action against the genotoxicity of DRC, since when no S9 fraction was added, the antimutagenic effect of fluphenazine was even stronger. However, inhibition of free radical pathways would not be the mechanism of the antimutagenic action exerted by fluphenazine against the simple alkylating agent, MMS. Thus, a search for mechanisms of fluphenazine's antimutagenic activity, besides the anti-free radical action, has been undertaken.
In human lymphocyte cultures we noticed that addition of fluphenazine to cells cultured in the presence of 16 µM B[a]P reduced the proliferation potential by 50% at the highest dose of the drug (5 µM). A detailed analysis of the proliferation potential showed a marked (ഛ40%) decrease in mitotic index and a mild (15%) decrease in replication index. At the highest excluded the possibility that fluphenazine was cytotoxic alone or when added together with standard mutagens. three standard mutagens; the effect was statistically significant When cells are genetically damaged, a decrease in proliferaat higher drug concentrations (i.e. 25-50 µM).
tion rate may help detoxification and repair of damage caused In the case of promutagen, B[a]P, the decrease in mutaby mutagens (Ames et al., 1993; Kaston and Kuerbitz, 1993 ; genicity found in the Ames test could be explained by Tomatis, 1993) . In response to DNA damage, the p53 gene fluphenazine inhibiting free radical pathways during mutagen becomes activated, and this triggers the transcription of genes processing by enzymes in the S9 fraction. The S9 microsomal involved in cell cycle arrest and/or apoptosis (e.g. Darnton, fraction from rat livers contains mixed-function oxidases, 1998; Taylor et al., 1999) . If apoptosis is induced in genetically including aromatic hydrocarbon hydroxylase, which can transdamaged cells by 'genome guardians' (the best-known of form B[a]P and other aromatic hydrocarbons to genotoxic which is the p53 gene product), this will lead to selective metabolites by two-electron oxidation processes (Gelboin, elimination of those cells that are unable to repair their DNA 1980; Frenkel, 1992 et al., 1999). Thus, apoptosis can be perceived as 'apoptotic pathways. The results demonstrated that free radical generation repair of genotoxically damaged tissue', which prevents fixaby human granulocytes in vitro was considerably inhibited in tion of damage and forestalls mutations (e.g. Kondo, 1998) .
the presence of fluphenazine. The regression equations and In this sense, factors that stimulate apoptosis in genetically analysis of variance showed that fluphenazine's inhibitory damaged cells are included in the family of antimutagenic effect strongly depended on the concentration of the drug in agents (e.g. DeFlora, 1998). The observed inhibition of lymphothe samples. cyte proliferation by fluphenazine in B[a]P-exposed cell culThe activation of a granulocyte oxidative burst caused by tures suggests that future studies on p53 expression and PMA is a consequence of the phorbol ester binding and apoptosis in such cultures might be interesting.
activating protein kinase C, a mediator of the major cellular In three short-term tests, fluphenazine decreased the genosignal transduction pathway (Blumberg, 1988; Tauber et al. , toxicity of mutagens towards lymphocyte cultures. The applied 1989). PMA binding and overactivation of the kinase can tests measure different end-points of genotoxicity: point explain a vast number of PMA biological activities, including mutations (the thioguanine resistance test), clastogenic and its influence on cellular proliferation, differentiation, carcinoaneuploidogenic action (the CBMN assay) and chromatid genesis and tumor promotion (Blumberg, 1988) . Phenothiazrearrangements (the sister chromatid exchange test). It should ines competitively inhibit the interaction between phorbol be stressed that, besides the marked differences in the esters and their specific cellular receptors (Shoyab et al., 1982) , effectiveness of fluphenazine, a statistically significant, dosewhich could be interpreted as their potentially antitumordependent decrease in the genotoxicity of standard mutagens promoting action. Our results describing the inhibitory action was established in every applied test (see legend to Figure 2) . of fluphenazine on the granulocyte free radical-generating Analysis of variance also showed that the antimutagenic system in the presence of PMA may also suggest an antitumoreffect of fluphenazine was significantly dependent on the promoting potency of the drug. Fluphenazine also decreased concentration of the drug in lymphocyte cultures, and showed considerably the level of granulocyte oxygen free radicals in that the applied tests differed significantly in their description the presence of B[a]P. The B[a]P-derived free radicals appear of the fluphenazine antimutagenic action. The differences to make up a significant part of the genotoxic by-products between the tests suggested that various mechanisms unequally (Dix and Marnet, 1981; Cavalieri and Rogan, 1992) and may contributed to the final antimutagenic effect of fluphenazine.
add their genotoxic action to DNA damage caused in vivo by The detailed mechanisms of the fluphenazine antimutagenic B[a]P metabolites formed with a bay-region diol epoxide action remain to be investigated in future. (Nesnow et al., 1995) . The decrease caused by fluphenazine We tried to confirm one possible mechanism of fluphenazine's antimutagenic action, i.e. inhibition of free radical in the level of free radicals in the presence of B[a]P might
